OTCPK:RAYT (Australia)  
Rayont Inc logo

Rayont Inc

$ 0.25 0 (0%) 11:08 AM EST
P/E:
At Loss
P/B:
2.63
Market Cap:
$ 12.02M
Enterprise V:
$ 15.03M
Volume:
-
Avg Vol (2M):
1.52K
Volume:
-
Market Cap $:
12.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.52K
Enterprise Value $:
15.03M
PB Ratio:
2.63
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset 0.55
Debt-to-Equity 0.67
Debt-to-EBITDA 12.76
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.98
Distress
Grey
Safe
Beneish M-Score -3.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 0.08
9-Day RSI 1.93
14-Day RSI 8.11
6-1 Month Momentum % -81.62
12-1 Month Momentum % -87.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.28
Quick Ratio 0.16
Cash Ratio 0.01
Days Inventory 126.85
Days Sales Outstanding 67.6
Days Payable 65.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -174.1

Financials

RAYT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RAYT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.662
EPS (TTM) ($) -0.027
Beta 5.28
Volatility % 88.48
14-Day RSI 8.11
14-Day ATR ($) 0.00512
20-Day SMA ($) 0.2875
12-1 Month Momentum % -87.64
52-Week Range ($) 0.2189 - 2.74
Shares Outstanding (Mil) 48.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rayont Inc Filings

Document Form Filing Date
No Filing Data

Rayont Inc Analysis

Share your research

Headlines

See More
No news.